1 Day
Source:
المشهد العربي
المشهد العربي
Ready to play
Ready to play
A small study has shown that women who receive genetically modified T cell therapy for autoimmune diseases can carry pregnancies safely after treatment. This therapy involves modifying white blood cells in the lab and then re-injecting them to help regulate the immune system. It is currently used to treat autoimmune conditions such as lupus, multiple sclerosis, and rheumatoid arthritis, which mainly affect women of reproductive age. The results confirm that this treatment does not prevent pregnancy, opening new possibilities for safely managing autoimmune diseases during pregnancy.
Notice: This Is an AI-Generated Summary
Comments (0)